Kamada Ltd. Total Liabilities 2011-2026 | KMDA

Annual Total Liabilities Kamada Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	32 M	38.5 M	25.7 M	32.6 M	33 M	29.5 M	38.7 M	49.4 M	60.7 M	62.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
62.8 M	25.7 M	40.3 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	6.06 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.56 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Coherus BioSciences CHRS	197 M	$ 1.63	-4.4 %	$ 191 M	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
Enlivex Therapeutics Ltd. ENLV	392 M	$ 0.73	-0.03 %	$ 33.4 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	57.2 M	$ 7.83	-5.21 %	$ 214 M	Israel
Athira Pharma ATHA	64.4 M	-	-	$ 269 M	USA
Esperion Therapeutics ESPR	768 M	$ 3.12	-	$ 649 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	71.5 M	-	0.74 %	$ 768 M	Israel
Exelixis EXEL	683 M	$ 51.1	-0.37 %	$ 13.9 B	USA
Forte Biosciences FBRX	21.8 M	$ 23.96	-2.84 %	$ 310 M	USA
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
Karyopharm Therapeutics KPTI	401 M	$ 8.9	0.56 %	$ 1.08 M	USA
AbCellera Biologics ABCL	390 M	$ 4.4	-7.76 %	$ 1.31 B	Canada
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	840 M	$ 17.3	-5.57 %	$ 809 M	USA
BioNTech SE BNTX	2.76 B	$ 91.99	-0.26 %	$ 22.2 B	Germany
Compugen Ltd. CGEN	18.5 M	$ 3.03	6.32 %	$ 283 M	Israel
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Gilead Sciences GILD	39 B	$ 132.06	-0.74 %	$ 164 B	USA
Genmab A/S GMAB	9.11 B	$ 26.9	1.32 %	$ 1.74 B	Danmark
Genprex GNPX	2.2 M	$ 0.86	1.2 %	$ 802 K	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.49	-4.12 %	$ 5.75 M	Israel
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Grifols, S.A. GRFS	12.8 B	$ 7.79	1.04 %	$ 5.29 B	Spain
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Fortress Biotech FBIO	123 M	$ 2.3	3.14 %	$ 64.2 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	243 M	$ 21.57	-0.55 %	$ 2.74 B	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Fennec Pharmaceuticals FENC	35.1 M	$ 9.24	36.48 %	$ 264 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA